Board of Directors.
Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides…click to learn more.
Management Team…click to learn more.
Board of Directors…click to learn more.
Helix BioMedix has assembled a strong team of leading dermatologists, peptide specialists, and pharmaceutical researchers to provide scientific support to our programs…click to learn more.
Helix BioMedix, Inc has partnered with leading fine ingredient suppliers and manufacturers to market our peptides in the consumer segment…click to learn more.
Information on Helix BioMedix

Board of Directors

R.Stephen Beatty
R. Stephen Beatty is Chief Executive Officer. He was appointed as Chairman of the Board in February 2015 and has served on the Board of Directors since May 1999. Prior to joining the Company, Mr. Beatty established and operated Beatty Finance, Inc., a private financial services company serving the legal profession. Prior to founding Beatty Finance, Inc., Mr. Beatty worked with BellSouth where he managed one of BellSouth’s corporate re-engineering teams, directed the development of enterprise software for BellSouth’s marketing division and was a member of BellSouth’s “Future Thinkers”, an in-house corporate think tank. Mr. Beatty obtained his Bachelor of Science in Mathematics with a minor in Economics from the University of South Alabama in 1975. He obtained his Masters in Business Administration from the University of New Orleans in 1997.
Robin L. Carmichael
Robin L. Carmichael was appointed our President in February of 2015 and has been our Chief Operating Officer in January 2011. Ms. Carmichael joined the Company in October 2007 as our Vice President of Marketing and Business Development. Prior to joining Helix, Ms. Carmichael most recently served as Chief Operating Officer of DERMAdoctor, Inc., a prestige skin company specializing in over-the-counter drugs and cosmeceuticals. She was Vice President of Marketing with ProCyte Corporation and Photomedex, Inc. following its acquisition of ProCyte in 2005, where she held a number of product marketing positions prior to her appointment as Vice President of Marketing in 1998. During her tenure at ProCyte, she developed and launched seven major product lines and created several new brands. In addition, she established the international distribution business and was actively involved with the various licensing partners. Ms. Carmichael has over 25 years of sales and marketing experience having held a number of regional and national sales positions in the life science and medical device companies, including Baxter Healthcare. She holds a Bachelor of Science in Nursing from Seattle University and attended the UCLA Anderson Graduate School of Executive Management. She is a recognized speaker and author on numerous topics, including peptides, cosmetic surgery and skin care and is a member of Cosmetic Executive Women.
John F. Clifford
John F. Clifford was elected to our board in August 2007. Mr. Clifford is a consultant in the Aesthetic and Dermatology markets. He was Executive Vice President of Dermatology for Photomedex from March 2005 until June 2006 following its acquisition of ProCyte Corporation. He was President, CEO and Chairman of ProCyte from 1996 until 2005. Before joining ProCyte, Mr. Clifford was the President of Orthofix, Inc. U.S., which acquired American Medical Electronics where he was CEO. From 1989 to 1994, he was employed by Davis and Geck, as Division Vice President. From 1964 to 1989, Mr. Clifford held various sales and marketing positions in Ethicon Inc., and Iolab Corp. both Johnson & Johnson companies. Mr. Clifford holds a B.S. in Economics from Villanova University and a M.B.A. in Finance from Drexel University.
Committees: Compensation
Richard M. Cohen
Richard M. Cohen joined our board in December 2005. Mr. Cohen has been the President of Richard M. Cohen Consultants since 1996. Richard M. Cohen Consultants is a financial services consulting company that accepts engagements from public and private companies to assist with their corporate finance and corporate governance needs. In addition, since 2003 Mr. Cohen has served as director of Dune Energy, Inc. a publicly traded company (AMES:DNE) for which he served as Chief Financial Officer from November 2003 to April 2005. Mr. Cohen also served as the Chief Financial Officer of Baseline Oil and Gas Corp. (OTBB:BOGA) a publicly held company with interests in oil/gas investments until August 2007. Mr. Cohen is a Certified Public Accountant (New York State). He received a B.S. from the University of Pennsylvania (Wharton) and a M.B.A. from Stanford University.
Committees: Audit Chairman
Lawrence Blake Jones
Lawrence Blake Jones has served as a member of our board of directors since March 2010. Since 1974, Mr. Jones has been a partner with Scheuermann & Jones, a Louisiana-based law firm that practices throughout much of the United States. In addition, he serves on the board of directors of First NBC Bank, a privately held financial institution, where he is a member of the audit committee, the board of directors of First Commerce Holding Company, a privately held holding company, where he is a member of the audit committee, and the national board of directors for the not-for-profit St. Jude’s Ranch for Children, where he is a member of the audit committee. He holds a J.D. from Tulane Law School and a B.A. in history from the Louisiana State University.
Committees: Audit, Governance